Balloon Catheters Peripheral

Last updated on September 09, 2015
CompanyProduct
Boston ScientificMustang Balloon Dilatation Catheter
Boston ScientificSterling Monorail PTA Balloon Dilatation Catheter
Boston ScientificSterling Over-the-Wire PTA Balloon Dilatation Catheter
Boston ScientificSterling SL Monorail and OTW Balloon Dilatation Catheters
Boston ScientificCoyote Over-The-Wire Balloon Dilatation Catheter
Boston ScientificCoyote Monorail Balloon Dilatation Catheter
Boston ScientificCoyote ES OTW and Coyote ES Monorail Balloon Dilatation Catheters
Boston ScientificPeripheral Cutting Balloon and Small Peripheral Cutting Balloon Devices
Boston ScientificCharger 0.035 Balloon Dilatation Catheter
Boston ScientificXXL Balloon Dilatation Catheter
Boston ScientificEqualizer Occlusion Balloon Catheter
CovidienEverCross PTA Balloon Catheter
CovidienPowerCross PTA Balloon Catheter
CovidienRapidCross PTA Balloon Catheter
CovidienNanoCross Elite PTA Balloon Catheter
MedtronicSprinter Legend RX
MedtronicSprinter Legend 1.25mm - Supercrosser
MedtronicNC Sprinter RX
MedtronicSprinter OTW
MedtronicNC Stormer OTW
MedtronicAdmiral Xtreme PTA Balloon Catheter
MedtronicIN.PACT Admiral
MedtronicAmphirion Deep OTW PTA Balloon Catheter
MedtronicAmphirion Plus OTW PTA Catheter
MedtronicPacific Plus OTW PTA Catheter
MedtronicPacific Xtreme PTA Balloon Catheter
MedtronicIN.PACT Pacific
MedtronicReef HP OTW PTA Balloon Catheter
MedtronicSubmarine Rapido OTW PTA Balloon Catheter
MedtronicReliant Stent Graft Balloon Catheter
Natec Medical LtdTamarin Blue
Natec Medical LtdFilao RX
Natec Medical LtdFilao NC
Natec Medical LtdEbony .035 OTW
Natec Medical LtdEbony .014 RX
Natec Medical LtdFilao CTO
Natec Medical LtdFilao OTW
Toray Industries, Inc."Inoue-Balloon" Catheter

Related Content

A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
Feature | Cath Lab | October 18, 2020
October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benef
A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020

A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin cap fibro-atheroma (TCFA).

News | Cath Lab | October 18, 2020
October 18, 2020 – Data from the...
The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0

The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions.

Feature | Cath Lab | October 16, 2020
October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary ar
Videos | Cath Lab | October 16, 2020
This is an example pf the Shockwave Medical Intravascular Lithotripsy (IVL) catheter system designed to break up heav
Videos | Cath Lab | July 15, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, offers an over
Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major
TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th